U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula C20H30O5
Molecular Weight 350.4492
Optical Activity UNSPECIFIED
Defined Stereocenters 3 / 3
E/Z Centers 5
Charge 0

SHOW SMILES / InChI
Structure of RESOLVIN E1

SMILES

CC[C@@H](O)\C=C\C=C/C[C@@H](O)\C=C\C=C\C=C/[C@@H](O)CCCC(O)=O

InChI

InChIKey=AOPOCGPBAIARAV-OTBJXLELSA-N
InChI=1S/C20H30O5/c1-2-17(21)11-8-5-9-14-18(22)12-6-3-4-7-13-19(23)15-10-16-20(24)25/h3-9,11-13,17-19,21-23H,2,10,14-16H2,1H3,(H,24,25)/b4-3+,9-5-,11-8+,12-6+,13-7-/t17-,18+,19-/m1/s1

HIDE SMILES / InChI

Molecular Formula C20H30O5
Molecular Weight 350.4492
Charge 0
Count
Stereochemistry ABSOLUTE
Additional Stereochemistry No
Defined Stereocenters 3 / 3
E/Z Centers 5
Optical Activity UNSPECIFIED

Resolvin E1 (RvE1 or RX-10001) is a trihydroxy eicosapentaenoic acid metabolite that has a role as an anti-inflammatory agent and a human xenobiotic metabolite. This compound binds to leukotriene B4 (BLT-1) on neutrophils and to ERV-1/ChemR23 on monocyte/macrophages. Resolvin E1 has been shown to reverse experimental periodontitis and dysbiosis in rats. Furthermore, in a murine model of Alzheimer’s disease, Resolvin E1 (in combination with lipoxin A4) decreased neuroinflammation. Resolvin E1 was also suggested as a potential therapeutic target for psoriasis. A phase I clinical trial to test drug safety in healthy volunteers has been completed in 2009.

Approval Year

PubMed

PubMed

TitleDatePubMed
Substance Class Chemical
Created
by admin
on Sat Dec 16 02:17:41 GMT 2023
Edited
by admin
on Sat Dec 16 02:17:41 GMT 2023
Record UNII
GND3JH08JA
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
RESOLVIN E1
Common Name English
5S,12R,18R-TRIHYDROXY-6Z,8E,10E,14Z,16E-EICOSAPENTAENOIC ACID
Systematic Name English
(5S,6Z,8E,10E,12R,14Z,16E,18R)-5,12,18-TRIHYDROXY-6,8,10,14,16-EICOSAPENTAENOIC ACID
Systematic Name English
RVE1
Common Name English
6,8,10,14,16-EICOSAPENTAENOIC ACID, 5,12,18-TRIHYDROXY-, (5S,6Z,8E,10E,12R,14Z,16E,18R)-
Systematic Name English
RX-10001
Code English
J2.218.407E
Code English
Code System Code Type Description
CAS
552830-51-0
Created by admin on Sat Dec 16 02:17:41 GMT 2023 , Edited by admin on Sat Dec 16 02:17:41 GMT 2023
PRIMARY
FDA UNII
GND3JH08JA
Created by admin on Sat Dec 16 02:17:41 GMT 2023 , Edited by admin on Sat Dec 16 02:17:41 GMT 2023
PRIMARY
DRUG BANK
DB13105
Created by admin on Sat Dec 16 02:17:41 GMT 2023 , Edited by admin on Sat Dec 16 02:17:41 GMT 2023
PRIMARY
CHEBI
91000
Created by admin on Sat Dec 16 02:17:41 GMT 2023 , Edited by admin on Sat Dec 16 02:17:41 GMT 2023
PRIMARY
PUBCHEM
10473088
Created by admin on Sat Dec 16 02:17:41 GMT 2023 , Edited by admin on Sat Dec 16 02:17:41 GMT 2023
PRIMARY
CHEBI
81559
Created by admin on Sat Dec 16 02:17:41 GMT 2023 , Edited by admin on Sat Dec 16 02:17:41 GMT 2023
PRIMARY
Related Record Type Details
DERIVATIVE -> PARENT
SALT/SOLVATE -> PARENT
Related Record Type Details
PRODRUG -> METABOLITE ACTIVE